Showing 3291-3300 of 5910 results for "".
- The Vision Council Announces that Version 3.13 of the Data Communication Standard is Now Availablehttps://modernod.com/news/the-vision-council-announces-that-version-313-of-the-data-communication-standard-is-now-available/2480893/The Vision Council announced the publication of Version 3.13 of the Standard for Data Communications. The standard, which is used by manufacturers of optical lab equipment and producers of software used in optical labs, was developed by The Vision Council’s Lens Proce
- Market Scope: Global PC-IOL Demand Rises Modestly, Soars in a Few Countrieshttps://modernod.com/news/market-scope-global-pc-iol-demand-rises-modestly-soars-in-a-few-countries/2480888/Presbyopia-correcting IOLs experienced steady global growth in 2021 and record-breaking growth in a handful of countries, according to a Market Scope re
- "Artificial Intelligence in Ophthalmology 2022" Conference is Being Held Onlinehttps://modernod.com/news/artificial-intelligence-in-ophthalmology-2022-conference-is-being-held-online/2480884/The "Artificial Intelligence in Ophthalmology 2022" conference is being held online on June 3, 2022. The conference will feature an overview of artificial intelligence (AI), machine learning (ML) and deep learning (
- Horizon Therapeutics Launches Letter-Writing Campaign to Empower Those Living with Thyroid Eye Disease (TED) to Confront the Condition Head Onhttps://modernod.com/news/horizon-therapeutics-launches-letter-writing-campaign-to-empower-those-living-with-thyroid-eye-disease-ted-to-confront-the-condition-head-on/2480860/For Mental Health Awareness Month and Healthy Vision Month in May, Horizon Therapeutics is partnering with mental health expert and New York Times best-selling author, Lori Gottlieb, to highlight the emotional burden of living with TED—a serious, progressive, and poten
- Life After Death for the Human Eye: Vision Scientists Revive Light-Sensing Cells in Organ Donor Eyeshttps://modernod.com/news/life-after-death-for-the-human-eye-vision-scientists-revive-light-sensing-cells-in-organ-donor-eyes/2480858/Scientists have revived light-sensing neuron cells in organ donor eyes and restored communication between them as part of a series of discoveries that stand to transform brain and vision research, accor
- SAV-IOL Launches Instant Focus EDOF IOL Technologyhttps://modernod.com/news/sav-iol-launches-instant-focus-edof-iol-technology/2480841/Instant Focus is a unique optical technology designed by Swiss IOL maker SAV-IOL (Swiss Advanced Vision). The technology is designed to replace the accommodative function of the eye’s natural lens after cataract surgery, and is manufactured and marketed directly from their he
- CooperVision Seeks Proposals for 2022 Science and Technology Awardshttps://modernod.com/news/coopervision-seeks-proposals-for-2022-science-and-technology-awards/2480832/To promote continuous advancement in contact lens research and development, CooperVision is now accepting submissions for its 2022 Science and Technology Awards program. The longstanding program fosters partnerships between recipients and CooperVision scientists to explore new dimensions in visio
- Ashvattha Therapeutics Presents Phase 1 Safety Data in Healthy Subjects for Subcutaneous Anti-VEGF Wet AMD and DME Candidatehttps://modernod.com/news/ashvattha-therapeutics-presents-phase-1-safety-data-in-healthy-subjects-for-subcutaneous-anti-vegf-wet-amd-and-dme-candidate/2480829/Ashvattha Therapeutics announced the presentation of safety data from a phase 1 study of its lead candidate D-4517.2, a VEGFR/PDGFR tyrosine kinase inhibitor conjugated to a hydroxyl dendrimer, at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, taking place in
- Opthea Names Quinton Oswald and Susan Orr, OD, to its Board of Directorshttps://modernod.com/news/opthea-names-quinton-oswald-and-susan-orr-od-to-its-board-of-directors/2480790/Opthea announced the appointment of Quinton Oswald and Susan Orr, OD, to its Board of Directors, effective immediately following election at a General Meeting of Shareholders on April 21st, 2022. Mr. Oswald and Dr. Orr have deep experience leading biotech companies and launching c
- Mireca Signs Deal with Graybug Vision to Develop Treatments for Inherited Retinal Diseaseshttps://modernod.com/news/mireca-signs-deal-with-graybug-vision-to-develop-treatments-for-inherited-retinal-diseases/2480755/